Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. ResMed Inc.
  6. Summary
    RMD   US7611521078

RESMED INC.

(RMD)
  Report
Delayed Quote. Delayed Nyse - 09/17 04:10:00 pm
285.95 USD   -0.08%
09/16INSIDER SELL : ResMed
MT
09/13INSIDER SELL : Resmed
MT
09/13RESMED : As Approved and Adopted by Board Resolution (Form 8-K)
PU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
288.9(c) 292.28(c) 290.42(c) 286.18(c) 285.95(c) Last
537 764 454 544 416 687 621 214 914 702 Volume
-2.26% +1.17% -0.64% -1.46% -0.08% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 3 800 M - -
Net income 2022 869 M - -
Net cash position 2022 77,0 M - -
P/E ratio 2022 48,6x
Yield 2022 0,65%
Sales 2023 4 012 M - -
Net income 2023 978 M - -
Net cash position 2023 653 M - -
P/E ratio 2023 44,6x
Yield 2023 0,69%
Capitalization 41 663 M 41 663 M -
EV / Sales 2022 10,9x
EV / Sales 2023 10,2x
Nbr of Employees 7 970
Free-Float 77,1%
More Financials
Company
ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep apnea, chronic obstructive pulmonary disease (COPD), neuromuscular disease and other chronic diseases. The Company operates through two segments: Sleep and Respiratory Care... 
More about the company
Ratings of ResMed Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about RESMED INC.
09/16INSIDER SELL : ResMed
MT
09/13INSIDER SELL : Resmed
MT
09/13RESMED : As Approved and Adopted by Board Resolution (Form 8-K)
PU
09/13RESMED INC : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fi..
AQ
09/09RESMED : Oppenheimer Adjusts ResMed PT to $312 From $300, Maintains Outperform R..
MT
09/08RESMED : Virtual Investor Day
PU
09/08RESMED : Announces Participation in the Bank of America Global Healthcare Confer..
AQ
09/08RESMED : People with Sleep Apnea Live Longer on CPAP in Large, Late-Breaking Res..
AQ
09/07INSIDER SELL : Resmed
MT
09/03INSIDER SELL : Resmed
MT
09/02RESMED : PAP-linked Survival Rate, New COPD Prevalence, Benefits of Telemonitori..
PU
09/02RESMED : Announces Participation in the Morgan Stanley 19th Annual Global Health..
AQ
08/27RESMED INC : Change in Directors or Principal Officers (form 8-K)
AQ
08/25RESMED : Announces SaaS Leadership Change
AQ
08/25ResMed Announces management changes
CI
More news
News in other languages on RESMED INC.
09/16VENTE D'INITIÉS : ResMed
09/13VENTE D'INITIÉS : Resmed
09/07VENTE D'INITIÉS : Resmed
09/03VENTE D'INITIÉS : Resmed
06/21Hoy en Wall Street: Una serie de discursos oficiales de la Fed está en camino
More news
Analyst Recommendations on RESMED INC.
More recommendations
Chart RESMED INC.
Duration : Period :
ResMed Inc. Technical Analysis Chart | RMD | US7611521078 | MarketScreener
Technical analysis trends RESMED INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Last Close Price 285,95 $
Average target price 260,00 $
Spread / Average Target -9,08%
EPS Revisions
Managers and Directors
Michael J. Farrell Chief Executive Officer & Director
Robert Andrew Douglas President & Chief Operating Officer
Brett A. Sandercock Chief Financial Officer
Peter C. Farrell Non-Executive Chairman
Carlos M. Nunez Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
RESMED INC.34.53%41 663
THERMO FISHER SCIENTIFIC20.32%234 792
DANAHER CORPORATION45.85%231 682
INTUITIVE SURGICAL, INC.26.79%123 426
SIEMENS HEALTHINEERS AG39.64%77 234
EDWARDS LIFESCIENCES CORPORATION32.29%74 438